• Nicotinamide Riboside Chloride: Applied Workflows for NAD+ R

  2026-06-13

  Nicotinamide Riboside Chloride (NIAGEN) is transforming metabolic dysfunction and neurodegenerative disease models with its high-purity, robust NAD+ boosting properties. This article delivers actionable experimental workflows, advanced troubleshooting, and comparative insights—unlocking precision for retinal, metabolic, and Alzheimer’s disease research.

• Nuclear cGAS-TRIM41 Axis Controls L1 Retrotransposition via

  2026-06-12

  This study reveals a nuclear role for cGAS in repressing LINE-1 (L1) retrotransposition through Chk2-dependent phosphorylation, which enhances TRIM41-mediated degradation of L1 ORF2p. The findings clarify a checkpoint mechanism linking the DNA damage response to retrotransposon control, with implications for genome stability in aging and cancer.

• Poly(I:C): Synthetic Double-Stranded RNA Analog for Immune A

  2026-06-12

  Poly(I:C) distinguishes itself as a synthetic double-stranded RNA analog by reliably activating innate immune pathways and enabling precise modeling of inflammatory responses. This article details advanced use-cases, workflow optimizations, and actionable troubleshooting tips for leveraging Poly(I:C) in translational research.

• Telomere Targeting in Latent HIV-1 Reservoirs Reveals DDR Vu

  2026-06-11

  This study demonstrates that latent HIV-1 infection in CD4+ memory T cells drives telomere elongation and creates a specific vulnerability to agents targeting telomeres and the DNA damage response (DDR). The findings reveal mechanistic insight into HIV reservoir persistence and highlight potential strategies for selective eradication beyond latency reversal.

• CH 223191: Advanced Strategies for AhR Antagonism in Microbi

  2026-06-11

  Explore the unique capabilities of CH 223191 as a potent aryl hydrocarbon receptor antagonist for dissecting the microbiota–tryptophan–AhR axis. This article provides a deep scientific analysis and actionable assay insights, distinguishing itself from existing resources.

• ECL Chemiluminescent Substrate Kit: Precision in Mechanistic

  2026-06-10

  Explore the ECL Chemiluminescent Substrate Detection Kit's mechanistic advantages for sensitive HRP-based assays. This article provides a deep dive into its unique utility for advanced protein and nucleic acid detection, with actionable insights for translational oncology.

• AAPH (2,2'-Azobis(2-methylpropionamidine) Dihydrochloride):

  2026-06-10

  This article explores how AAPH (2,2'-Azobis(2-methylpropionamidine) Dihydrochloride) (SKU C5140) serves as a gold standard oxidative stress inducer for reproducible in vitro models. Through scenario-driven Q&A, we address real-world laboratory challenges and provide evidence-based guidance for protocol optimization, data interpretation, and vendor selection.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-09

  This study demonstrates that male and female mice show distinct responses to chronic angiotensin II infusion, with males developing more pronounced hypertension and females displaying relative protection. The findings reveal key roles for sex hormones and baroreflex regulation in hypertensive mechanisms, providing a foundation for modeling sex-specific cardiovascular responses.

• Anlotinib Hydrochloride: Mechanistic Insights and Translatio

  2026-06-09

  Explore the unique mechanistic and translational advantages of Anlotinib hydrochloride, a potent multi-target tyrosine kinase inhibitor. This article provides in-depth scientific analysis and practical assay guidance for researchers focused on angiogenesis and tumor biology.

• EZ Cap™ EPO mRNA: Advanced Workflows for Neurorepair & Eryth

  2026-06-08

  EZ Cap™ EPO mRNA (ψUTP) from APExBIO empowers translational researchers with a stabilized, highly translatable mRNA for targeted neurorepair and erythropoiesis applications. The latest reference studies illustrate how optimized delivery of human erythropoietin mRNA overcomes previous barriers to protein expression and neuroprotection, enabling robust in vitro and in vivo models.

• BMP4-GPX4 Axis Mitigates Ferroptosis in Glaucoma Stem Cell M

  2026-06-08

  This study demonstrates that activating the BMP4-GPX4 pathway reduces ferroptosis and supports the differentiation of retinal stem cells into retinal ganglion cells in a high intraocular pressure glaucoma model. The findings provide mechanistic insight into neuroprotection and suggest new avenues for improving stem cell-based therapies in glaucoma.

• Annexin V-PE Apoptosis Detection Kit: Precision in Live-Cell

  2026-06-07

  The Annexin V-PE Apoptosis Detection Kit enables rapid, fixation-free detection of apoptosis in live cells by targeting phosphatidylserine externalization. This evidential review details its mechanism, benchmarking, and protocol integration, underlining its unique value for apoptosis research.

• Sex Differences in Angiotensin II-Induced Hypertension in Mi

  2026-06-06

  This study provides direct evidence that male and female mice differ significantly in their blood pressure responses to chronic angiotensin II infusion, with males exhibiting a greater hypertensive response. These findings clarify the influence of sex hormones on hypertension development and underscore the critical importance of considering sex as a biological variable in cardiovascular research.

• SU5416 (Semaxanib): Redefining Translational Angiogenesis Re

  2026-06-05

  Explore how SU5416 (Semaxanib) enables next-generation studies on VEGF-driven angiogenesis, tumor vascularization, and immune modulation, leveraging mechanistic precision and translational flexibility. This article bridges current biomarker discovery in pulmonary vascular disease and advanced cancer models, providing actionable guidance for researchers seeking transformative experimental strategies.

• L-Phenylephrine: Precision α1A Receptor Agonist for Cardiova

  2026-06-05

  L-Phenylephrine empowers researchers to model adrenergic α1A receptor signaling with high selectivity, enabling nuanced investigations of cardiovascular and neural mechanisms. This guide details optimized protocols, troubleshooting, and sex-specific assay design leveraging APExBIO's high-purity reagent.

455 records 15/31 page Previous Next First page 上5页 1112131415 下5页 Last page